65,437 trials
Adult Cholangiocarcinoma · Advanced Adult Hepatocellular Carcinoma · BCLC Stage C Adult Hepatocellular Carcinoma
Primary: Overall Survival — 4.3; 7.9 months — p=0.05
Dental Caries
Primary: Percentage Surface Micro Hardness Recovery (% SMH), of Brushing for 2 Minutes Versus (vs.) Brushing for 45 Seconds With 1.5g of Experimental Dentifrice. — 41.61; 34.66 %…
Acute Coronary Syndrome
Primary: Number of Participants With First Occurrence of Any Event in the Composite of Major Coronary Events During the Time Period for Follow-up (FU) of Cardiovascular (CV)…
Stress Urinary Incontinence · Urinary Incontinence
Primary: "Much Better" or "Very Much Better" on PGI-I at 3 Months — 80; 72; 59 Participants — p=<0.0492
Helicobacter Pylori Infection
Primary: Number of Participants in Which H. Pylori Was Eradicated — 154; 154 participants
Renal Impairment · Hepatic Impairment
Primary: AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration for Free Form of TAK-272 (TAK-272F) and Its…
Osteoarthritis, Knee
Primary: Knee Injury and Osteoarthritis Outcome Score (KOOS Pain Rating) at 5-7 Weeks Post-Treatment — 59; 53; 56 units on KOOS scale
Stroke · Cerebrovascular Accident
Primary: Change in Fugl Meyer Assessment Motor Score — 7.4; 3.4; 7.2; 2.8 units on a scale
Tardive Dyskinesia
Primary: Abnormal Involuntary Movement Scale (AIMS) Dyskinesia Total Score — 9.9; 9.1; 8.8 units on a scale — p=0.5880
Hyperparathyroidism
Primary: Parathyroid Hormone Following 1 Week of ACE Inhibitor Administration — 70.9; 32.5 pg/mL — p=0.049
Sickle Cell Anemia · Sickle ß0-Thalassemia
Primary: The Number of Occurrences of Sickle Cell Crises — 3; 4 Number of crises — p=0.0052
Non-Hodgkin's Lymphoma
Primary: Percentage of Patients With Complete Response to the Combination Chemotherapy — 75.0; 23.0 Percentage of participants
Carcinoma, Squamous Cell · Head and Neck Neoplasms · Oropharyngeal Neoplasms
Primary: Pathologic Complete Response Rate After De-escalated CRT in HPV-positive and/or p16 Positive Oropharyngeal Squamous Cell Carcinoma (OPSCC). — 37 Participants
Painful Diabetic Neuropathy · Diabetic Neuropathy · Neuropathy
Primary: Change From Baseline to Day 84 (Week 12) in Numeric Pain Rating Scale Score — -1.2; -1.4 units on a scale — p=0.3361
Urothelial Carcinoma
Primary: Overall Response Rate — 11 Participants